Pure Global Cannabis Inc. (TSX.V:PURE; OTC: PRCNF)  (the “Company” or “Pure Global” or “PURE”), a vertically integrated growth-oriented life sciences cannabis company, announced today that its shares are now listed on the Berlin, Munich and Stuttgart stock exchanges under the “WKN:A2JQ26” and the ticker symbol “1QS”. The company anticipates its Frankfurt listing imminently. The company’s shares continue to be listed on the TSXV under the ticker “PURE” and on the OTC market in the US under the ticker symbol “PRCNF”.

The company has also announced that is has appointed Deutsche Gesellschaft für Wertpapieranalyse GmbH (“DGWA” – www.dgwa.org), a boutique European investment and financial markets consulting firm based in Frankfurt, Germany to support the Company’s existing German listing. The appointment of DGWA, an accomplished Frankfurt and Berlinbased Investment Banking Boutique will support Pure Global in expanding the profile of the Company’s global investor base across Europe.


“Our listing in Germany is an important milestone for Pure Global as we continue to expand our international awareness and investor base. This will allow European investors to participate in PURE’s ongoing significant growth and expansion,” said Malay Panchal, President & CEO of Pure Global. “Pure Global Cannabis is very well positioned to grow within the EU and across the global cannabis market as  countries continue to adopt new cannabis regulations.”

Mr Stefan Müller is the CEO and founder of DGWA and graduated as a banker, beginning his career at Dresdner Bank AG as senior vice president of global equity trading. He has held senior positions with Equinet AG, Bankhaus Sal Oppenheim (largest European private bank at that time) as head of global proprietary trading and managing partner at Proprietary Partners AG, a Swiss based hedge fund advisory company.

Importantly DGWA consults to various companies, investors, institutions and federal organizations regarding their investment strategy.

Commenting on DGWA’s appointment, Mr Müller said:

“DGWA is pleased to be working with the Pure Global team as they expand their presence in the European market. There is significant interest within Europe for regulated medical cannabis companies and we believe Pure Global Cannabis is one of the most attractive companies listed today. Pure Global Cannabis will be of particular interest to European retail, institutional and strategic investors as many are seeking greater exposure to global cannabis revolution.”

About Pure Global Cannabis

Pure Global Cannabis Inc. (TSXV:PURE; OTC: PRCNF) is a vertically-integrated, growth-oriented life sciences cannabis company led by experienced pharma-industry, horticultural, consumer packaged goods (CPG), and supply chain experts. The Company’s wholly owned subsidiary, PureSinse Inc., is a licensed producer under the Access to Cannabis for Medical Purposes Regulations (ACMPR) focused on producing cannabis products for medical, wellness, health & beauty, natural health, and future legal adult use markets.

About DGWA – www.dgwa.org

Deutsche Gesellschaft für Wertpapieranalyse GmbH (“DGWA”) is a German Institute for asset management and a boutique European investment and financial markets consulting firm based in Frankfurt and Berlin, Germany. The management team have a 25-year track record in trading, investing and analysing SME’s around the world. DGWA has been involved in over 250 IPO’s, financings, bond issues, dual listings and corporate finance transactions as well as coordinating roadshows and awareness campaigns.

To register to Pure Global’s mailing list, please visit www.pureglobal.com. Follow @pureglobalcanna on Twitter and Facebook and @pureglobalcannabis on Instagram.

FORWARD-LOOKING STATEMENTS

This news release contains certain forward-looking statements, including, but not limited to, statements about Pure Global’s future plans and intentions.  Wherever possible, words such as “may”, “will”, “should”, “could”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict” or “potential” or the negative or other variations of these words, or similar words or phrases, have been used to identify these forward-looking statements. These statements reflect management’s current beliefs and are based on information currently available to management as at the date hereof.

Forward-looking statements involve significant risk, uncertainties and assumptions. Many factors could cause actual results, performance or achievements to differ materially from the results discussed or implied in the forward-looking statements. These factors should be considered carefully and readers should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management believes to be reasonable assumptions, Pure Global cannot assure readers that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and Pure Global assumes no obligation to update or revise them to reflect new events or circumstances, except as required by law.

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

For further information: regarding Pure Global, please contact: Stephen Pynn, VP Corporate Development, Telephone: 1-866-899-PURE (7873), E-mail: stephen@pureglobal.com; Malay (Mel) Panchal, President & CEO, Telephone: 1-866-899-PURE (7873), E-mail: info@pureglobal.com

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less